+34 620 10 75 37info@nanbiosis.com

Posts Taged rei-jaume-i-award

Laura Lechuga awarded the 2020 Rei Jaume I Prize in New Technologies

The Valencian Government (Generalitat Valenciana), together with the Foundation Premios Rei Jaume I, announced today the awardees of the 32th edition of the Rei Jaume I Awards, one of the highest recognitions for a research career in Spain. Prof. Laura M. Lechuga Gomez, Full Professor of the Spanish National Research Council (CSIC), head of the NANBIOSIS U4 Biodeposition and Biodetection Unit  and the Nanobiosensors and Bioanalytical Applications Group (of CIBER-BBN and the ICN2), has received the New Technologies Award.

Prof. Laura M. Lechuga received her PhD in Chemistry from the University Complutense of Madrid (Spain) in 1992. The principal focus of her research is the development of novel nanobiosensor devices based on nanoplasmonics and silicon-based photonics principles, including surface biofunctionalization, microfluidics for automatic fluid delivery and complete lab-on-a-chip integration for point-of-care devices. The use of nanobiosensor devices for a wide range of challenging clinical and environmental applications is one of her main objectives.

She has published over 270 articles, book chapters and proceedings, has 8 families of patents, and has presented her work worldwide in more than 350 invited talks. She has co-founded two spin-offs companies. has been Adjunct Professor at The Artic University of Norway (2012-2016) and Distinguished Visiting professor at University of Campinas (Brazil) (2013-2017). Prof. Lechuga is Associate Editor of Analyst (RSC) and has been Associate Editor in other two Physics and Engineering Journals. She is a member of the Scientific Advisory Board of several high-level research Centres around the world and has taken part in numerous international evaluation panels. Prof. Lechuga has also participated in many EU funded projects (some of them as Coordinator) and has been part of various EU Evaluation Panels in the 6th, 7th and H2020 Framework Programmes (including Adv. ERC panels).

The other awardees of this year’s edition are: 

  • In Basic Research: Francisco José García Vidal 
  • in Economy: Diego Puga Pequeño 
  • in Medical Research: Miguel Beato del Rosal
  • in Environment Protection: Fernando Maestre Gil
  • in Entrepreneur: Verónica Pascual Boé

Each of the six categories is awarded with 100,000 euros to be used mainly for research and innovation activities, a gold medal and diploma.

The prizes are aimed to recognize people whose work is highly significant and has significantly contributed to the advancement of their research field having been developed for the most part in Spain. Prof. Laura M. Lechuga Gomez receives the New Technologies Award for her long innovative career in the field of nanobiosensors.

The gury has specifically recognized hes important contributions to the design and development of new essential biosensors for early and rapid clinical diagnosis, hes outstanding groundbreaking research in silicon photonics and nanoplasmic results in ultrasensitive tagless detection, the microfluidics and lab integration on a chip, what enabled real devices at the point of care with many bioanalytical applications, as well as the creation of spin-off companies that impact our society and its economy.

Prof. Lechuga has previously received several prizes and recognitions along her career, such as the Prize of Physics, Innovation and Technology from the Spanish Royal Society of Physics and BBVA Foundation in 2016, the Fellow of the Optical Society (OSA) award in 2014,  the Ada Byron Prize for Technological Women in 2020 among others.

Read More

Nanomedicine: how to get drugs to the place where they have to act.

At the beginning of June, the Jury of the Rei Jaume I 2018 Awards, formed by Nobel Prize winners, businessmen and scientists, met in Valencia to choose the winners.

Today has taken place the ceremony of delivery of the 30th edition of the awards presided over by King Felipe VI. Among the six winners, in the category of New Technologies was Ramón Martínez Mañez, Scientific Director of the CIBER-BBN and Unit 26 of NANBIOSIS.

Coinciding with its thirtieth anniversary, the Rei Jaume Foundation has produced a series of videos of interviews with the winners. In this video, Ramón Martínez Mañez, Scientific Director of Unit 26 of NANBIOSIS, who has received the Rei Jaume I Award for New Technologies, talks about the two major areas in which he works and other topics such as the recognition of science and the need to recover the talent of researchers who go out of Spain and a better connection between research and the company. Some of his answers are the following:

One of our lines of research is in the field of sensors: systems based on nanotechnology for the detection of substances such as the presence of pathogens that may be harmful to health. The other major area is nanomedicines for the controlled release of drugs, one of the fundamental ideas of nanomedicine is how to get drugs to the place where they have to act.

Recognition in science is obtained if your works are cited, having social recognition is much more difficult.

We are a good country in science but we are a country in the second division in the transfer of science to the companies, it is needed more investment so that the products end up coming to the market or so that more research is done in collaboration with companies in Spain.

It is good to leave Spain, not necessarily to succeed but to see how they work in other places. The problem that exists today is that it is very difficult to return to Spain and this is a pity because there are very well educated and very good people who stay abroad.

Read More

Ramón Martínez Máñez Master class on Nanomedicine at the Act of the Academic Opening year 2018-2019  of Spanish university

On September 25, the Polytechnic University of Valencia hosted the Solemn Act of the new Academic Opening year 2018-2019  of Spanish universities, coinciding with the commemoration of its 50th anniversary. This institutional act was chaired by S.M. King Felipe VI, the Minister of Science, Innovation and Universities, Pedro Duque, and the President of the Generalitat Valenciana, Ximo Puig, among many other authorities.

Ramón Martínez Máñez, has been in charge of teaching the master class of the new academic year. Ramón Martínez is professor of the Department of Chemistry of the UPV and director of the Interuniversity Research Institute of Molecular Recognition and Technological Development, besides Scientific Director of CIBER-BBN and Scientific Director of NANBIOSIS U26 NMR: Biomedical Applications II

In the master class, Martínez Máñez explained that nanomedicine aims to “identify diseases in their early stages at the cellular and molecular level through the use of nanodevices and contrast systems” in order to “provide an early diagnosis and, therefore, improve the prognosis of the disease“. Ramón Martínez Mañez, Rei Jaume I Award for New Technologies 2018 has underlined that, nanomedicine “is already a well-established area of ​​knowledge that seeks to apply the continuous advances of nanotechnology to medicine” and that “there are numerous studies that demonstrate its great capacity for the development of new diagnostic devices, new systems for the controlled release of drugs and materials suitable for the development of tissues.  In fact, as indicated “there are already in the market biomedical solutions based on nanotechnology such as nanoformulated drugs.” For the professor of the UPV, “we do not know what is the future of medicine, but without a doubt nanotechnology will play an important role in its development and, although we do not know who will carry out these advances, undoubtedly, the research developed in the university it will play a fundamental role “.

Read More